Uni.-Prof. Dr. Friedemann Johannes Weber
ORCID: https://orcid.org/0000-0001-9737-337X Researcher ID: AAB-3425-2019 |
Projekte als Projektleitung
- SARS-CoV-2 und das antivirale Inferonsystem
01.07.2021 - 31.12.2021
Bundesministerium für Forschung, Technologie und Raumfahrt, ehemals: Bundesministerium für Bildung und Forschung (BMFTR, BMBF) - RAPID II - Innate Immunity-Phänotyp von Viren
01.10.2020 - 30.09.2021
Bundesministerium für Forschung, Technologie und Raumfahrt, ehemals: Bundesministerium für Bildung und Forschung (BMFTR, BMBF) - MAD-CoV 2 - Modern approaches for developing antivirals against SARS-CoV 2
01.08.2020 - 31.07.2024
Europäische Union (EU) - OPENCORONA - Rapid therapy development through Open nCoronavirus Vaccine Platform
01.04.2020 - 31.03.2022
Europäische Union (EU) - KFO 309 TP - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies - Teilprojekt: Systematische Analyse der anti-viralen Aktivität des Pathogen-Erkennungs-Rezeptors RIG-I in der Influenza Virus Infektion: Neue Zielstrukturen für antivirale Interventionsstrategien
01.03.2020 - 28.02.2023
Deutsche Forschungsgemeinschaft (DFG)
Projekte als Co-Investigator oder weiteres Projektmitglied
- GRK 2355/2 - Regulatorische Netzwerke im mRNA-Lebenszyklus: von kodierenden zu nichtkodierenden RNAs
01.01.2023 - 30.06.2027
Deutsche Forschungsgemeinschaft (DFG) - KFO 309/2 - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies
01.01.2020 - 30.06.2024
Deutsche Forschungsgemeinschaft (DFG) - GRK 2355/1 - Regulatorische Netzwerke im mRNA-Lebenszyklus: von kodierenden zu nichtkodierenden RNAs
01.07.2018 - 31.12.2022
Deutsche Forschungsgemeinschaft (DFG) - KFO 309/1 - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies
01.11.2016 - 30.06.2020
Deutsche Forschungsgemeinschaft (DFG)
- Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation (2009)
- Journal of General Virology
- Journal of VirologyCytokine & Growth Factor Reviews
Journalartikel- Severe Acute Respiratory Syndrome Coronavirus Triggers Apoptosis via Protein Kinase R but Is Resistant to Its Antiviral Activity (2009)
- Journal of VirologyPLoS ONE
Journalartikel - Species-independent bioassay for quantification of antiviral type-I interferons based on luciferase-expressing Rift Valley fever virus (2009)
- CytokineCytokine
Meeting Abstract - Tick-borne encephalitis virus delays interferon induction and is very sensitive to the interferon-stimulated gene viperin (2009)
- Cytokine
Meeting Abstract - Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus (2009)
- Virology
Journalartikel - Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response (2008)
- Journal of Medical VirologyCytokine
Journalartikel - Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis (2008)
- Cytokine & Growth Factor Reviews
Journalartikel - Interferon and cytokine responses to SARS-coronavirus infection (2008)
Journalartikel - Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction (2008)
Journalartikel - SARS-coronavirus inhibits interferon induction both at pre- and post-transcriptional levels (2008)
Meeting Abstract - T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus (2008)
- Journal of General Virology
Journalartikel - The Interferon Antagonist ML Protein of Thogoto Virus Targets General Transcription Factor IIB (2008)
- Journal of Virology
Journalartikel - The interferon sensitivity of tick-borne encephalitis virus is partially mediated by double-stranded RNA-dependent protein kinase (2008)
- Cytokine
Meeting Abstract - Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter (2008)
Meeting Abstract